| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | GW PHARMACEUTICALS PLC | 41,487 | 5,507,000 | 2.07% | ||
| 52 | CHEMBIO DIAGNOSTICS INC COM NEW | 771,676 | 5,710,000 | 2.14% | ||
| 53 | IMMUNOMEDICS INC | 7,500,000 | 6,333,000 | 2.38% | PRN | |
| 54 | AKEBIA THERAPEUTICS INC | 700,000 | 6,335,000 | 2.38% | ||
| 55 | CAS MED SYS INC | 3,845,365 | 6,647,000 | 2.50% | ||
| 56 | MARVELL TECHNOLOGY GROUP LTD | 510,000 | 6,768,000 | 2.54% | ||
| 57 | ACADIA PHARMACEUTICALS INC COM | 220,000 | 6,998,000 | 2.63% | ||
| 58 | Ascendis Pharma | 363,000 | 7,296,000 | 2.74% | ||
| 59 | EDGE THERAPEUTICS INC | 703,000 | 7,318,000 | 2.75% | ||
| 60 | NEURODERM LTD | 462,956 | 8,560,000 | 3.21% | ||
| 61 | SPDR SER TR | 150,000 | 9,944,000 | 3.73% | Put | |
| 62 | AERIE PHARMACEUTICALS INC COM | 280,000 | 10,567,000 | 3.97% | ||
| 63 | FCB Financial Holdings Inc | 1,550,000 | 11,920,000 | 4.48% | ||
| 64 | IMMUNOMEDICS INCORPORATED | 3,850,000 | 12,513,000 | 4.70% | ||
| 65 | IRIDEX CORP | 1,220,611 | 17,687,000 | 6.64% | ||
| 66 | VERACYTE INC | 3,144,649 | 23,931,000 | 8.99% | ||
| 67 | LION BIOTECHNOLOGIES INC COM | 3,229,916 | 26,582,000 | 9.98% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001493152-16-014991, filed 2016.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
